Search In this Thesis
   Search In this Thesis  
العنوان
Comparative study between the Efficacy of Pyridoxine Combined Cyclizine and Metoclopramide in the Management of Nausea and Vomiting with Pregnancy /
المؤلف
Abd Elhalim,Abo Bakr Mohamed
هيئة الاعداد
باحث / أبوبكر محمد عبدالحليم
مشرف / محمد علاء محى الدين الغنام
مشرف / أيمن عبدالرازق أبوالنور
مشرف / شريف فكري عبدالله هنداوي
تاريخ النشر
2017
عدد الصفحات
152.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض النساء والتوليد
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Obstetrics and Gynecology
الفهرس
Only 14 pages are availabe for public view

from 152

from 152

Abstract

Abstract
Introduction Nausea and vomiting are among the cardinal symptoms of early pregnancy, recognized as such since at least the time of Hippocrates. In contemporary Western societies, an estimated 50% to 80% of pregnant women experience nausea and/or vomiting during the first trimester of pregnancy. The problem is generally time-limited, with onset about the fifth week after the last menstrual period (LMP), a peak at 8 to 12 weeks, and resolution by 16 to 18 weeks for most women; approximately 5% of women will have symptoms throughout pregnancy Conclusion. Nausea and vomiting of pregnancy (NVP) is a debilitating condition affecting many pregnant women. Up to 90% of pregnant women will experience NVP of varying severity, with symptoms generally starting around 4–9 weeks of gestation, peaking around the 7th to 12th week, and subsiding by the 16th week. NVP symptoms will appear prior to ten weeks of gestation; women who experience NVP symptoms for the first time after 10 weeks, may be experiencing nausea and vomiting due to other medical conditions. The diagnosis of NVP is clinical in nature, and although other causes of persistent nausea, retching and/or vomiting are rarely encountered, failure to distinguish them from NVP can result in serious complications. Generally it has been observed that women who experience NVP have better pregnancy outcomes than those who don’t, and women who use antiemetics appear to have better pregnancy outcomes than women with NVP who don’t receive treatment. One explanation for this is that women who use antiemetics, tend to experience severe NVP which may be associated with a more robust placenta secreting high levels of hCG hormones; thus the better outcome for the antiemetic group of women could be attributed to the placenta itself and not so much the therapy.
Key words: Helicobacter ,Human chorionic gonadotropin; ,Hyperemesis gravidarum , Immunoglobulin .